medsci-skills 4.1.0

package/skills/find-journal/references/journal_profiles/Chest.md

@@ -0,0 +1,39 @@
+# CHEST
+
+## Identity
+- **Abbreviation:** Chest
+- **Publisher:** Elsevier on behalf of the American College of Chest Physicians (ACCP)
+- **ISSN:** 0012-3692 / 1931-3543
+- **Homepage:** https://journal.chestnet.org/
+- **Author guidelines:** https://journal.chestnet.org/content/authors
+
+## Scope
+CHEST publishes clinical research, reviews, and evidence-based guidelines in pulmonary medicine, critical care, and sleep medicine, emphasizing work with direct practice impact. Coverage spans COPD, asthma, lung cancer and nodule management, interstitial lung disease, pulmonary hypertension, venous thromboembolism, mechanical ventilation and sepsis/ARDS, sleep-disordered breathing, bronchoscopy, and chest imaging (including Lung-RADS and Fleischner-guideline research).
+
+## Scope Keywords
+pulmonary medicine, COPD, emphysema, asthma, lung cancer, lung nodule, Lung-RADS, interstitial lung disease, pulmonary fibrosis, pulmonary embolism, critical care, mechanical ventilation, ARDS, sepsis, sleep apnea, pulmonary hypertension, chest imaging, bronchoscopy, smoking cessation
+
+## Article Types Accepted
+- Original Research (unsolicited; 300-word structured abstract; 3,200 words; 50 refs)
+- Research Letter (1,000 words; 10 refs)
+- Systematic Review (without MA; 3,200 words; 75 refs)
+- Scoping Review (3,200 words; 50 refs)
+- Guidelines and Consensus Statements (4,000 words; 150 refs)
+- Narrative Review (invited; 3,500 words; 75 refs)
+- Special Feature (invited; 3,500 words; 75 refs)
+- How I Do It (invited; 3,000 words; 50 refs)
+- Point/Counterpoint + Dilemma Debate (invited)
+- Editorials / CHEST Commentary (invited)
+- Case sections (online only): Novel Reports, Chest Imaging & Pathology for Clinicians, CHEST Pearls, Ultrasound Corner
+- Humanities in CHEST Medicine (Case-Based Discussion, Consilia Historiae, Vantage, Exhalations, Original Research)
+- Letter to the Editor / Response (400 words; 5 refs)
+
+## Classification
+- **Tier:** Q1
+- **Open Access:** Hybrid (APC $4,160; CC BY-NC-ND default, CC BY for mandated funders)
+- **Field:** Pulmonary medicine / Critical care / Sleep medicine
+
+## Special Notes
+Flagship journal of the American College of Chest Physicians (ACCP). **Double-anonymized peer review** via Editorial Manager — submission requires separate uploads for cover letter, title page (author details), and a fully anonymized manuscript. CHEST uses distinctive terminology: "Research Question" (not Objective), "Study Design and Methods" (not Methods), and "Interpretation" (not Conclusion) in both the 6-section structured abstract and main-text section headings. A Take-Home Point pullout (3 short sentences) is required at submission. Lung imaging studies (CT screening, nodule detection AI, COPD/emphysema quantification) are well within scope when linked to clinical endpoints. **Tobacco-industry-funded research is not accepted.** Systematic reviews with meta-analysis are submitted as Original Research, not as Systematic Reviews. AI policy: generative AI disclosure required when used for readability/language — add a "Declaration of Generative AI and AI-assisted technologies in the writing process" section before the References list; AI tools cannot be authors.
+
+<!-- Source verification: Author guidelines pasted by maintainer 2026-04-20; ISSN/publisher confirmed against journal masthead. Promoted from private tier to public on 2026-04-20. -->

package/skills/find-journal/references/journal_profiles/Clinical_Radiology.md

@@ -0,0 +1,30 @@
+# Clinical Radiology
+
+## Identity
+- **Abbreviation:** Clin Radiol
+- **Publisher:** Elsevier (Royal College of Radiologists, RCR)
+- **ISSN:** 0009-9260 / 1365-229X
+- **Homepage:** https://www.clinicalradiologyonline.net/
+- **Author guidelines:** https://www.clinicalradiologyonline.net/content/authorinfo
+
+## Scope
+Clinical Radiology publishes original research, reviews, case reports, and pictorial reviews across all areas of diagnostic and interventional radiology. As the official journal of the Royal College of Radiologists, it emphasizes clinical practice, service improvement, and evidence-based radiology with particular relevance to UK and Commonwealth healthcare systems.
+
+## Scope Keywords
+clinical radiology, diagnostic imaging, CT, MRI, ultrasound, interventional radiology, radiology practice, NHS radiology, audit, quality improvement, radiation dose, screening, radiology training, AI in radiology, radiological anatomy, pictorial review
+
+## Article Types Accepted
+- Original Article
+- Review Article
+- Technical Note
+- Case Report
+- Pictorial Review
+- Letter to the Editor
+
+## Classification
+- **Tier:** Q2
+- **Open Access:** Hybrid (Elsevier OA option)
+- **Field:** Radiology / General
+
+## Special Notes
+Clinical Radiology is the official journal of the Royal College of Radiologists (RCR). British English is mandatory throughout. The journal values studies with practical relevance to UK radiology practice, including NHS audit and quality improvement work. Pictorial reviews with educational value are a strength. For European multicenter studies, consider European Radiology; for higher-impact general radiology, consider Radiology or AJR.

package/skills/find-journal/references/journal_profiles/Clinical_and_Molecular_Hepatology.md

@@ -0,0 +1,32 @@
+# Clinical and Molecular Hepatology
+
+## Identity
+- **Abbreviation:** Clin Mol Hepatol
+- **Publisher:** Korean Association for the Study of the Liver (KASL)
+- **ISSN:** 2287-2728 / 2287-285X
+- **Homepage:** https://www.e-cmh.org
+- **Author guidelines:** https://www.e-cmh.org/authors/authors.php
+
+## Scope
+Clinical and Molecular Hepatology is the KASL flagship journal publishing original basic and clinical research on liver diseases. Particularly receptive to Korean and Asian cohort epidemiology, MASLD/NAFLD natural history, chronic hepatitis B/C management, HCC surveillance, and studies citing KASL practice guidelines.
+
+## Scope Keywords
+hepatology, liver disease, MASLD, NAFLD, MetALD, ALD, chronic hepatitis B, chronic hepatitis C, hepatocellular carcinoma, HCC, cirrhosis, liver fibrosis, FIB-4, Korean cohort, Asian epidemiology, KASL guidelines, 2023 SLD nomenclature, lean MASLD, fatty liver, liver transplantation
+
+## Article Types Accepted
+- Original Article
+- Review Article (invited; unsolicited reviews accepted for peer review)
+- Editorial (invited)
+- Special Topic (guidelines, meeting reports, hepatology issues elsewhere)
+- Letter to the Editor (online-only; within 2 years of cited article)
+- Correspondence (online-only; reply to editorial)
+- Research Letter (online-only; concise original study)
+- Snapshot (graphical single-page summary)
+
+## Classification
+- **Tier:** Q1 hepatology
+- **Open Access:** Full OA (APC US$1,500 since 2024-02-05)
+- **Field:** hepatology, observational cohort epidemiology, Korean/Asian clinical research
+
+## Special Notes
+KASL flagship journal with strong preference for Korean screening-cohort epidemiology and 2023 SLD nomenclature applications. Original articles require a mandatory graphical abstract (531×531 px, 600 dpi) and structured abstract (Background/Aims, Methods, Results, Conclusions). Fast-track review available for US$1,000 with 7-day first decision. AI policy: follows ICMJE — disclose AI use in Acknowledgements with software name, version, manufacturer, dates, and description of use; AI cannot be author; citation of AI-generated material as primary source is prohibited.

package/skills/find-journal/references/journal_profiles/Diabetes_Metabolism_Journal.md

@@ -0,0 +1,36 @@
+# Diabetes & Metabolism Journal
+
+## Identity
+- **Abbreviation:** Diabetes Metab J
+- **Publisher:** Korean Diabetes Association (KDA)
+- **ISSN:** [TODO: verify at e-dmj.org]
+- **Homepage:** https://e-dmj.org
+- **Author guidelines:** https://e-dmj.org/authors/authors.php
+
+## Scope
+Diabetes & Metabolism Journal is the official English-language journal of the Korean Diabetes Association covering diabetes mellitus, metabolic disorders, and endocrinology — clinical, epidemiological, and basic-science research. The journal is particularly receptive to Korean and East Asian population studies addressing diabetes epidemiology, prevention, treatment, complications, body composition, metabolic syndrome, and related cohort outcomes.
+
+## Scope Keywords
+diabetes mellitus, type 2 diabetes, metabolic syndrome, body composition, sarcopenia, sarcopenic obesity, hepatic steatosis, MASLD, insulin resistance, HOMA-IR, glycaemic control, prediabetes, Korean cohort, East Asian population, KDA, diabetes prevention, diabetes complications, endocrinology, lipid disorders
+
+## Article Types Accepted
+- Original Article (4,000 words, abstract <250, refs ≤50, ≤6 figures/tables)
+- Review Article (abstract <200, refs ≤150)
+- Brief Report (1,500 words, abstract <180, refs ≤20, ≤2 figures)
+- Editorial (refs ≤20)
+- Letter to the Editor (1,000 words, refs ≤10, 1 figure or 1 table)
+
+## Classification
+- **Tier:** Q2 (specialty diabetes/endocrinology journal)
+- **Open Access:** Full OA, Creative Commons Attribution Non-Commercial License (CC BY-NC)
+- **Field:** Diabetes / Endocrinology / Metabolic Disease
+
+## Special Notes
+Diabetes & Metabolism Journal is the KDA flagship English-language journal, bimonthly (Jan/Mar/May/Jul/Sep/Nov). Double-blind peer review ensuring both authors and reviewers remain anonymous. Strict 4,000-word body limit for Original Article (excluding abstract, references, legends); structured abstract (Background-Methods-Results-Conclusion) ≤250 words; 3–10 MeSH keywords. Reporting guidelines mandated per study design (CONSORT/STROBE/PRISMA/CARE). Figure resolution ≥300 DPI in JPEG/EPS/TIFF/PICT format. AI policy: authors must disclose AI tool, version, manufacturer, and writing role on the title page; AI cannot be listed as author; AI-generated images prohibited. Particularly receptive to Korean and East Asian diabetes cohort studies and body-composition / metabolic-outcome research with single-institution observational designs.
+
+
+---
+
+## Verification
+- **Source:** https://e-dmj.org/authors/authors.php
+- **Date:** 2026-05-21

package/skills/find-journal/references/journal_profiles/Diagnostic_and_Interventional_Radiology.md

@@ -0,0 +1,32 @@
+# Diagnostic and Interventional Radiology
+
+## Identity
+- **Abbreviation:** Diagn Interv Radiol (DIR)
+- **Publisher:** Galenos Publishing House (Turkish Society of Radiology)
+- **ISSN:** 1305-3825 / 1305-3612
+- **Homepage:** https://www.dirjournal.org/
+- **Author guidelines:** https://www.dirjournal.org/ (Instructions to Authors)
+
+## Scope
+Bimonthly, double-blind, fully open-access journal covering diagnostic and interventional radiology — original investigations, reviews, meta-analyses, pictorial essays, and technical notes across all radiology subspecialties. Indexed in SCIE, PubMed/MEDLINE, PMC, Scopus, EMBASE, DOAJ.
+
+## Scope Keywords
+diagnostic radiology, interventional radiology, imaging, CT, MRI, ultrasound, PET, angiography, embolization, biopsy, ablation, image-guided therapy, radiology AI, diagnostic accuracy, meta-analysis, technical note, pictorial essay, Turkish radiology
+
+## Article Types Accepted
+- Original Article (4500w, 400w structured abstract with PURPOSE/METHODS/RESULTS/CONCLUSION/CLINICAL SIGNIFICANCE)
+- Review Article (4000w)
+- Meta-Analysis (4000w, 200w structured abstract, PRISMA flowchart required)
+- Pictorial Essay (1500w)
+- Technical Note (1500w)
+- Letter to the Editor / Reply (500w)
+- Commentary (invited, 1200w)
+- Editorial (invited, 1200w)
+
+## Classification
+- **Tier:** Q2
+- **Open Access:** Full OA (APC on acceptance: $1000 Meta-Analysis/Original, $1250 Review, $750 Pictorial Essay/Technical Note)
+- **Field:** Radiology (diagnostic and interventional)
+
+## Special Notes
+Turkish Society of Radiology official journal; double-blind review with mandatory statistics consultant for all original articles. Editorial office desk-returns for format non-compliance — critical items include 5-subheading capitalized structured abstract (PURPOSE/METHODS/RESULTS/CONCLUSION/CLINICAL SIGNIFICANCE), 3–5 Main Points between Abstract and Introduction, explicit IRB + informed consent statements in Methods (including N/A declarations for SR/MA), parenthetical (not superscript) references in AMA style, supplementary files as Word (not PDF), and iThenticate similarity ≤20% overall / ≤5% single-source. AI policy: follows ICMJE — disclose AI use in Methods.

package/skills/find-journal/references/journal_profiles/Endocrinology_and_Metabolism.md

@@ -0,0 +1,37 @@
+# Endocrinology and Metabolism
+
+## Identity
+- **Abbreviation:** Endocrinol Metab (EnM)
+- **Publisher:** Korean Endocrine Society (KES)
+- **ISSN:** [TODO: verify at e-enm.org]
+- **Homepage:** https://e-enm.org
+- **Author guidelines:** https://e-enm.org/authors/authors.php
+
+## Scope
+Endocrinology and Metabolism is the official English-language journal of the Korean Endocrine Society covering endocrinology, metabolism, hormonal disorders, thyroid, adrenal, pituitary, bone metabolism, diabetes, and lipid metabolism — clinical, epidemiological, and basic-science research. The journal is particularly receptive to Korean and East Asian population studies on endocrine disorders and to research with explicit hormonal-axis or endocrine-mechanism framing.
+
+## Scope Keywords
+endocrinology, metabolism, thyroid disorders, adrenal disorders, pituitary disorders, bone metabolism, osteoporosis, diabetes mellitus, type 2 diabetes, lipid metabolism, dyslipidaemia, metabolic syndrome, hormonal axis, hormone replacement, Korean cohort, East Asian population, KES, mineral metabolism, calcium homeostasis, endocrine oncology
+
+## Article Types Accepted
+- Original Article (abstract ≤250, refs ≤50)
+- Review Article (abstract ≤200, refs ≤150)
+- Brief Report (1,200 words, abstract ≤150 unstructured, refs ≤20, ≤2 figures)
+- Editorial (1,000 words, refs ≤20)
+- Image (1,000 words, refs ≤5)
+- Letter to the Editor (1,000 words, refs ≤10, ≤1 figure)
+
+## Classification
+- **Tier:** Q2 (specialty endocrinology journal)
+- **Open Access:** Full OA, content freely available
+- **Field:** Endocrinology / Metabolism / Hormonal Disorders
+
+## Special Notes
+Endocrinology and Metabolism is the KES flagship English-language journal. Double-blind peer review with three anonymous specialist reviewers; review period capped at 3 months. Structured abstract (Background-Methods-Results-Conclusion) ≤250 words for Original Article. Reporting guidelines mandated per study design (CONSORT/STROBE/PRISMA/STARD). Figure resolution >300 DPI in JPEG/GIF/TIFF/BMP/PICT format with sequential Arabic numerals and letter sub-panels. AI policy: authors must clearly describe AI use in both manuscript and cover letter; AI cannot be listed as author; non-disclosure results in rejection or retraction. Particularly receptive to Korean and East Asian endocrinology studies and to research framed around hormonal-axis or endocrine-mechanism discussion. Body composition, diabetes, and metabolic syndrome research benefits from explicit endocrine framing in the manuscript narrative.
+
+
+---
+
+## Verification
+- **Source:** https://e-enm.org/authors/authors.php
+- **Date:** 2026-05-21

package/skills/find-journal/references/journal_profiles/European_Journal_of_Preventive_Cardiology.md

@@ -0,0 +1,39 @@
+# European Journal of Preventive Cardiology (EJPC)
+
+## Identity
+- **Abbreviation:** Eur J Prev Cardiol
+- **Publisher:** Oxford University Press (on behalf of the European Association of Preventive Cardiology and the European Society of Cardiology)
+- **ISSN:** 2047-4881 (online)
+- **Homepage:** https://academic.oup.com/eurjpc
+- **Author guidelines:** https://academic.oup.com/eurjpc/pages/general-instructions
+
+## Scope
+EJPC addresses the causes and risk factors of cardiovascular diseases, as well as cardiovascular prevention, rehabilitation, exercise physiology and sport cardiology. The journal is the flagship outlet of the European Association of Preventive Cardiology (EAPC) within the European Society of Cardiology (ESC) family.
+
+## Scope Keywords
+preventive cardiology, cardiovascular epidemiology, cardiovascular risk factors, primary prevention, secondary prevention, cardiac rehabilitation, exercise physiology, sport cardiology, lifestyle medicine, lipids, hypertension, diabetes, cardiovascular-kidney-metabolic, CKM staging, coronary artery calcium, subclinical atherosclerosis, cardiovascular screening, observational cohort, behavioral cardiology
+
+## Article Types Accepted
+- Full Research Paper
+- Clinical Practice / Education
+- Review
+- Editorial
+- Rapid Communication
+- Letter to the Editor
+- Cardialogue
+
+## Classification
+- **Tier:** Q1
+- **Open Access:** Hybrid (subscription default; OA option available, APC not listed on the Author Guidelines page — verify at OUP open-access pricing portal)
+- **Field:** Preventive cardiology — European society flagship
+
+## Special Notes
+Full Research Papers are capped at **5,000 words**, 6 figures/tables, and 100 references with a **structured 250-word abstract using Aims / Methods / Results / Conclusion**. References use **Vancouver numbered style with first 6 authors listed; if more than 6, use 'et al.'**. AI policy (verbatim): "Natural language processing tools driven by artificial intelligence (AI) do not qualify as authors, and the Journal will screen for them in author lists. The use of AI (for example, to help generate content or images, write code, process data, or for translation) should be disclosed in a cover letter at the point of submission and explained in full in a Methods or Acknowledgements section." Submission portal: https://www.editorialmanager.com/ejpc/default.aspx. EJPC is the natural home for cardiovascular prevention studies linking risk factor clustering to incident outcomes — including CKM staging, transition pattern, and early-metabolic-window analyses. Choose EJPC over JAHA when the primary framing is preventive (transitions, screening, lifestyle) rather than general cardiovascular outcomes, and over Atherosclerosis when the cohort design and prevention narrative outweigh the lipid/plaque-biology angle.
+
+
+---
+
+## Verification
+- **Source:** https://academic.oup.com/eurjpc/pages/general-instructions
+- **Date (harvested from private profile):** 2026-05-20
+- **Date (promoted to public):** 2026-05-21

package/skills/find-journal/references/journal_profiles/European_Radiology.md

@@ -0,0 +1,29 @@
+# European Radiology
+
+## Identity
+- **Abbreviation:** Eur Radiol
+- **Publisher:** Springer Nature (European Society of Radiology)
+- **ISSN:** 0938-7994 / 1432-1084
+- **Homepage:** https://www.springer.com/journal/330
+- **Author guidelines:** https://www.springer.com/journal/330/submission-guidelines
+
+## Scope
+European Radiology publishes original research and reviews across all subspecialties of diagnostic and interventional radiology, with emphasis on multi-center studies, AI/radiomics validation, and imaging innovations relevant to European and international clinical practice.
+
+## Scope Keywords
+diagnostic radiology, interventional radiology, CT, MRI, ultrasound, radiomics, AI in radiology, multi-center studies, oncologic imaging, cardiac imaging, musculoskeletal imaging, neuroradiology, abdominal imaging, breast imaging, contrast agents, quantitative imaging
+
+## Article Types Accepted
+- Original Article
+- Review Article
+- Technical Note
+- Case Report
+- Letter to the Editor
+
+## Classification
+- **Tier:** Q1
+- **Open Access:** Hybrid (Springer Open Choice)
+- **Field:** Radiology (general)
+
+## Special Notes
+European Radiology is the official journal of the European Society of Radiology (ESR) and one of the highest-impact general radiology journals. Requires 3 Key Points (max 85 characters each) as declarative statements. Uses British English throughout. Strongly prefers multi-center studies with N >= 200 for original articles. AI policy: follows ICMJE — disclose AI use in Methods. **Graphical abstract mandatory** from first revision for all Original Articles (Jan 2025). Official template: EURA-GA-Jan2025.pptx.

package/skills/find-journal/references/journal_profiles/Hepatology_Communications.md

@@ -0,0 +1,40 @@
+# Hepatology Communications
+
+## Identity
+- **Abbreviation:** Hepatol Commun
+- **Publisher:** Wolters Kluwer Health, Inc. for AASLD (American Association for the Study of Liver Diseases)
+- **ISSN:** 2471-254X (online-only, fully open access)
+- **Homepage:** https://journals.lww.com/hepcomm
+- **Author guidelines:** https://edmgr.ovid.com/hepcomm/accounts/ifauth.htm
+- **Submission portal:** https://mc.manuscriptcentral.com/hepcomm
+
+## Scope
+Hepatology Communications is the AASLD-published, peer-reviewed, online-only, fully open-access companion to Hepatology, dedicated to fast dissemination of high-quality basic, translational, and clinical research in hepatology. Authors retain copyright; articles are immediately and freely available to read and share.
+
+## Scope Keywords
+hepatology, liver disease, MASLD, NAFLD, MASH, NASH, MetALD, ALD, alcohol-associated liver disease, chronic hepatitis B, chronic hepatitis C, HCC, hepatocellular carcinoma, cirrhosis, liver fibrosis, FIB-4, liver transplantation, basic hepatology, translational hepatology, clinical hepatology, MASLD nomenclature
+
+## Article Types Accepted
+- Original Research Article (≤ 5,000 words; abstract 275 words; ≤ 50 references; ≤ 8 figures/tables)
+- Review (≤ 5,000 words, invited preferred)
+- Editorial (≤ 1,500 words; invited; "Viewpoints" unsolicited considered)
+- Research Letter (≤ 1,000 words; clinical research only; no abstract; ≤ 10 refs; ≤ 1 table or figure)
+- Correspondence (500–750 words)
+- Special Articles (AASLD practice guidelines, in-depth reviews, social policy ≤ 5,000 words)
+- Protocol Paper (pre-registered ongoing trials/studies; ≤ 5,000 words)
+- Consensus Report (≤ 2,000 words; ≤ 9 refs)
+
+## Classification
+- **Tier:** Q1 hepatology (AASLD family)
+- **Open Access:** Full OA, mandatory CC BY or CC BY-NC-ND license
+- **Field:** hepatology — basic, translational, clinical
+
+## Special Notes
+AASLD's open-access companion to Hepatology — receives transferred submissions from Hepatology and other AASLD/Wiley liver journals, often with prior peer-review portable. Mandates the 2023 MASLD/MASH revised nomenclature in submitted manuscripts unless explicitly justified ("Manuscripts ... should employ this revised terminology wherever scientifically appropriate"). PaperPal Preflight pre-submission check available. STROBE checklist mandatory for cohort/cross-sectional studies. AI policy follows ICMJE: AI use must be disclosed in Materials and Methods AND cover letter, AI cannot be author, AI-generated text/images must be reviewed for accuracy by author who takes full responsibility. Initial submission allowed in single Word file with no strict formatting; revisions must use 1.5-spaced 10–12 pt body.
+
+## Article Processing Charges (verified from PDF, 2025 rates)
+- Tier 1 (Articles, Reviews, Experimental Research): AASLD member US$1,890 / non-member US$3,150
+- Tier 2 (Letters, Editorials, Correspondence): AASLD member US$480 / non-member US$800
+
+## Acceptance Rate (estimated)
+~30–35 % (AASLD/Wiley OA companion typically more accepting than parent Hepatology; PubsHub editor reports 2024).

package/skills/find-journal/references/journal_profiles/Hepatology_International.md

@@ -0,0 +1,37 @@
+# Hepatology International
+
+## Identity
+- **Abbreviation:** Hepatol Int
+- **Publisher:** Springer Nature on behalf of APASL (Asian Pacific Association for the Study of the Liver)
+- **ISSN:** 1936-0533 / 1936-0541
+- **Homepage:** https://link.springer.com/journal/12072
+- **Author guidelines:** https://link.springer.com/journal/12072/submission-guidelines
+- **Editorial Manager:** https://www.editorialmanager.com/heip
+
+## Scope
+Hepatology International is the official journal of APASL, publishing original basic, translational, and clinical research in hepatology with strong representation of Asia-Pacific cohorts and disease patterns. Particularly prominent for MASLD/NAFLD natural history in East-Asian populations, chronic hepatitis B (regional endemic), HCC surveillance, and APASL-aligned guideline-relevant work.
+
+## Scope Keywords
+hepatology, liver disease, MASLD, NAFLD, lean MASLD, MetALD, ALD, chronic hepatitis B, hepatitis C, HCC, hepatocellular carcinoma, cirrhosis, liver fibrosis, FIB-4, APASL guidelines, Asia-Pacific cohort, Asian liver disease, ACLF, acute-on-chronic liver failure, liver transplantation, biomarkers
+
+## Article Types Accepted
+- **Original Article** (≤ 4,000 words including references; abstract 250 words structured; 10 keywords; **graphical abstract MANDATORY**; ≤ 30 references; ≤ 6 tables/figures combined)
+- Review Article (≤ 5,000 words; abstract 250 words; ≤ 100 refs; ≥ 4 colored figures and ≥ 4 tables MANDATORY; total up to 8 illustrations)
+- Mini Review (≤ 2,500 words excluding refs; abstract 150 words; ≤ 30 refs; ≥ 2 figures recommended; total up to 4 illustrations)
+- Invited Article / Editorial (by invitation only; ≤ 1,500 words; ≤ 10 refs; 1 figure)
+- Consensus Report (≤ 2,000 words; ≤ 9 refs)
+- Letter to Editor (≤ 500 words; ≤ 5 refs; 1 figure)
+- Point-of-View (by invitation; ≤ 1,500 words; ≤ 10 refs; 1 table + 2 figures)
+- Commentary (by invitation; ≤ 1,500 words; ≤ 10 refs; 1 table + 1 figure)
+- Multimedia / Dynamic Articles (with embedded video supplements ≤ 9 min)
+
+## Classification
+- **Tier:** Q1 hepatology (APASL flagship)
+- **Open Access:** Hybrid (OA optional via Springer's Open Choice; APC ~US$3,090 for OA)
+- **Field:** hepatology — clinical and translational, Asia-Pacific emphasis
+
+## Special Notes
+Copyright on accepted manuscripts is held by APASL (mandatory Copyright/Authorship/Disclosure Form signed by all authors at submission). Original Articles must include a single-panel graphical abstract (300 dpi+, .tif/.jpg, Arial 12–16 pt, RGB) placed next to abstract — labelled "Graphical Abstract" — this is one of the journal's strictest unique requirements. STROBE for cohort studies, PRISMA for SR/MA, STARD for diagnostic accuracy, ARRIVE for animals are required to be cited and uploaded as supplemental. Compliance with Ethical Requirements section (CoI / informed consent / human-and-animal-rights) goes on the title page only. Strong fit for Korean cohort epidemiology — sister society KASL is a long-standing APASL member, and Korean MASLD natural-history papers are well represented in recent volumes.
+
+## Acceptance Rate (estimated)
+~25–30 % (Springer/APASL editor reports; Hepatol Int sits between CMH (KASL) and parent Hepatology in selectivity).

package/skills/find-journal/references/journal_profiles/IEEE_JBHI.md

@@ -0,0 +1,28 @@
+# IEEE Journal of Biomedical and Health Informatics
+
+## Identity
+- **Abbreviation:** IEEE J Biomed Health Inform, IEEE JBHI
+- **Publisher:** IEEE (Institute of Electrical and Electronics Engineers)
+- **ISSN:** 2168-2194 / 2168-2208
+- **Homepage:** https://www.embs.org/jbhi/
+- **Author guidelines:** https://www.embs.org/jbhi/author-information/
+
+## Scope
+IEEE JBHI publishes research on information technology and its application to biomedical and health data. Coverage spans biomedical signal processing, wearable sensors, health monitoring, medical image analysis, bioinformatics, telemedicine, and AI-driven clinical decision support. The journal bridges electrical engineering, computer science, and health sciences.
+
+## Scope Keywords
+biomedical signal processing, wearable sensors, health monitoring, ECG analysis, EEG analysis, medical image analysis, deep learning healthcare, IoT health, telemedicine, bioinformatics, clinical decision support, federated learning, edge computing health, physiological signals, health informatics
+
+## Article Types Accepted
+- Regular Paper
+- Short Paper
+- Survey Paper
+- Correspondence
+
+## Classification
+- **Tier:** Q1
+- **Open Access:** Hybrid (IEEE Open Access option)
+- **Field:** Biomedical engineering / Health informatics
+
+## Special Notes
+IEEE JBHI is one of the top IEEE journals for health-related AI and engineering research. It values technical depth in signal processing, systems engineering, and algorithm design alongside clinical relevance. The journal is strong in wearable/sensor-based health AI, federated learning for healthcare, and multimodal health data fusion. IEEE formatting and citation style required.

package/skills/find-journal/references/journal_profiles/IEEE_TMI.md

@@ -0,0 +1,28 @@
+# IEEE Transactions on Medical Imaging
+
+## Identity
+- **Abbreviation:** IEEE Trans Med Imaging
+- **Publisher:** IEEE (Institute of Electrical and Electronics Engineers)
+- **ISSN:** 0278-0062 / 1558-254X
+- **Homepage:** https://ieeexplore.ieee.org/xpl/RecentIssue.jsp?punumber=42
+- **Author guidelines:** https://www.embs.org/tmi/authors/
+
+## Scope
+IEEE Transactions on Medical Imaging publishes original research on the formation, processing, and analysis of medical images. Coverage includes imaging physics, reconstruction algorithms, image segmentation, registration, detection, classification, and computer-aided diagnosis across all modalities (CT, MRI, PET, ultrasound, X-ray, microscopy, pathology). Emphasis is on algorithmic novelty and mathematical rigor with validation on medical imaging data.
+
+## Scope Keywords
+medical imaging, image reconstruction, image segmentation, image registration, deep learning, convolutional neural networks, computed tomography, magnetic resonance imaging, ultrasound, pathology, computer-aided detection, object detection, image classification, self-supervised learning, transformer, generative models, physics-informed networks, federated learning
+
+## Article Types Accepted
+- Regular Paper (12 pages, IEEE 2-column)
+- Short Paper (6 pages)
+- Correspondence (3 pages)
+- Special Issue Papers
+
+## Classification
+- **Tier:** Q1
+- **Open Access:** Hybrid (IEEE OA option)
+- **Field:** Medical imaging / Biomedical engineering
+
+## Special Notes
+IEEE TMI uses strict page limits (12 pages including figures, tables, and references in IEEE 2-column format) rather than word limits. LaTeX with IEEEtran class is standard. The journal frequently publishes extended versions of MICCAI/ISBI conference papers (requiring 30%+ new content). Technical novelty in imaging methodology is required; clinical application alone without algorithmic contribution is insufficient. Papers typically include ablation studies, comparison with state-of-the-art, and computational cost analysis.

package/skills/find-journal/references/journal_profiles/INSI.md

@@ -0,0 +1,29 @@
+# Interventional Neuroradiology
+
+## Identity
+- **Abbreviation:** Interv Neuroradiol
+- **Publisher:** SAGE Publications (ESMINT / WFITN)
+- **ISSN:** 1591-0199 / 2385-2011
+- **Homepage:** https://journals.sagepub.com/home/INI
+- **Author guidelines:** https://journals.sagepub.com/author-instructions/INI
+
+## Scope
+Interventional Neuroradiology publishes original research, reviews, and case reports on endovascular and minimally invasive neuroradiology, including cerebrovascular interventions, mechanical thrombectomy, aneurysm treatment, AVM embolization, and novel neurovascular devices.
+
+## Scope Keywords
+neurointerventional radiology, mechanical thrombectomy, cerebral aneurysm, flow diversion, coiling, AVM embolization, dural arteriovenous fistula, carotid stenting, intracranial atherosclerosis, stroke intervention, venous sinus stenting, tumor embolization, spinal vascular intervention, neurovascular devices, endovascular treatment
+
+## Article Types Accepted
+- Original Article
+- Review Article
+- Technical Note
+- Case Report
+- Letter to the Editor
+
+## Classification
+- **Tier:** Q2
+- **Open Access:** Hybrid (SAGE Choice)
+- **Field:** Interventional neuroradiology
+
+## Special Notes
+Interventional Neuroradiology is the official journal of ESMINT and WFITN, dedicated exclusively to minimally invasive neurovascular procedures. Accepts smaller case series (N=5-20) for novel techniques as technical notes. Requires explicit reporting of all complications including minor ones. Choose INSI over AJNR when the study is purely about interventional technique, devices, or endovascular outcomes. AI policy: follows ICMJE — disclose AI use in Methods.

package/skills/find-journal/references/journal_profiles/Investigative_Radiology.md

@@ -0,0 +1,25 @@
+# Investigative Radiology
+
+## Identity
+- **Abbreviation:** Invest Radiol
+- **Publisher:** Wolters Kluwer / Lippincott Williams & Wilkins
+- **ISSN:** 0020-9996 / 1536-0210
+- **Homepage:** https://journals.lww.com/investigativeradiology/
+- **Author guidelines:** https://journals.lww.com/investigativeradiology/pages/informationforauthors.aspx
+
+## Scope
+Investigative Radiology publishes original research on novel imaging techniques, contrast agents, imaging physics, and translational imaging science, emphasizing early and timely publication of diagnostic imaging advances with high methodological rigor.
+
+## Scope Keywords
+contrast agents, imaging physics, MRI techniques, CT technology, molecular imaging, quantitative imaging, imaging biomarkers, diffusion imaging, perfusion imaging, spectroscopy, photon-counting CT, dual-energy CT, ultrafast MRI, translational imaging, preclinical imaging, gadolinium
+
+## Article Types Accepted
+- Original Research
+
+## Classification
+- **Tier:** Q1
+- **Open Access:** Hybrid (CC BY-NC-ND)
+- **Field:** Radiology / Imaging science
+
+## Special Notes
+Investigative Radiology is a highly selective journal focused on imaging science and technology rather than clinical case series. It does not accept case reports, reviews, or technical notes — only original research. Known for rapid publication of novel contrast agent studies and imaging physics advances. AI policy: AI use discouraged, must disclose in cover letter and Acknowledgments.

package/skills/find-journal/references/journal_profiles/JACC_Advances.md

@@ -0,0 +1,41 @@
+# JACC: Advances
+
+## Identity
+- **Abbreviation:** JACC Adv
+- **Publisher:** Elsevier (on behalf of the American College of Cardiology)
+- **ISSN:** 2772-963X (online; full open access)
+- **Homepage:** https://www.sciencedirect.com/journal/jacc-advances
+- **Author guidelines:** https://www.sciencedirect.com/journal/jacc-advances/publish/guide-for-authors
+
+## Scope
+JACC: Advances provides a global forum for clinical research articles and timely reviews focused on advances in cardiovascular medicine. Content areas include arrhythmia and electrophysiology, cardio-obstetrics, cardiovascular surgery, congenital heart disease, coronary heart disease, critical care cardiology, digital health, genetics, geriatric cardiology, global health, health services research, heart failure, imaging, interventional cardiology, and other cardiovascular fields. The journal strives to appeal to authors across the spectrum of the cardiovascular care team at every career stage and considers original research articles, including applied clinical, epidemiological, and health care policy papers related to cardiovascular and cerebrovascular diseases.
+
+## Scope Keywords
+cardiovascular medicine, cardiovascular research, epidemiology, prevention, cardio-metabolic, cardiovascular-kidney-metabolic, CKM staging, coronary artery calcium, cardiac CT, atherosclerosis, heart failure, hypertension, diabetes, dyslipidemia, screening cohort, observational study, health services research, digital health, global cardiology
+
+## Article Types Accepted
+- Original Research Papers
+- State-of-the-Art Reviews
+- Methodology Corner
+- Brief Reports
+- Research Letters
+- Viewpoints
+- Letters to the Editor (and Replies)
+- Editorial Comments
+- JACC: Advances Expert Panel
+
+## Classification
+- **Tier:** Emerging Q1 (JACC family, full open access)
+- **Open Access:** Full Gold OA — APC USD 3,024 (Original Research / Reviews / Methodology / Expert Panel); USD 1,300 (Research Letters / Brief Reports). 10% discount for ACC members and early-career authors (≤10 years post-training); 50% discount for authors from developing countries.
+- **Field:** Cardiovascular medicine — broad
+
+## Special Notes
+Editor-in-Chief Candice K. Silversides, MD (University Health Network, University of Toronto). Original Research is capped at **5,000 words** (including text, references, and figure legends) with a **structured 250-word abstract using Background / Objectives / Methods / Results / Conclusions**. State-of-the-Art Reviews and Expert Panels permit ≤10,000 words with an unstructured 150-word abstract; Brief Reports ≤1,200 words and Research Letters ≤1,000 words, each capped at 1 simple figure/table. References use **Vancouver superscript numerals** with "list all authors if 6 or fewer, otherwise list the first 3 and add et al." (journal titles italicized). The Guide for Authors does not display a journal-specific AI policy; Elsevier publisher-level policy applies — AI cannot be listed as an author, AI use in writing must be disclosed in a dedicated declaration immediately before the references, and AI may not be used to create or alter images. Submission portal: https://www.jaccsubmit-advances.org. As of 2026-05-20 the journal is not yet indexed for an Impact Factor (Web of Science indexing pending) — use it for novel framework applications where AHA-aligned editorial assessment is helpful and a global open-access audience matters more than IF.
+
+
+---
+
+## Verification
+- **Source:** https://www.sciencedirect.com/journal/jacc-advances/publish/guide-for-authors
+- **Date (harvested from private profile):** 2026-05-20
+- **Date (promoted to public):** 2026-05-21

package/skills/find-journal/references/journal_profiles/JACC_Asia.md

@@ -0,0 +1,30 @@
+# JACC: Asia
+
+## Identity
+- **Abbreviation:** JACC Asia
+- **Publisher:** Elsevier (American College of Cardiology)
+- **ISSN:** 2772-3747 (online)
+- **Homepage:** https://www.jacc.org/journal/jacc-asia
+- **Author guidelines:** https://www.sciencedirect.com/journal/jacc-asia/publish/guide-for-authors
+
+## Scope
+JACC: Asia is the open-access sister journal in the JACC family devoted to cardiovascular research relevant to Asian populations and Asian healthcare systems. It publishes original investigations, state-of-the-art reviews, and clinical commentaries on epidemiology, prevention, imaging, interventional cardiology, electrophysiology, heart failure, and structural heart disease, with priority for Asian-data-driven evidence and Asia-Pacific clinical practice.
+
+## Scope Keywords
+cardiovascular medicine, Asia-Pacific cardiology, coronary artery disease, coronary calcium, cardiac CT, cardiac MRI, atherosclerosis, heart failure, atrial fibrillation, hypertension, dyslipidemia, diabetes, MASLD, cardio-metabolic, structural heart disease, valvular heart disease, interventional cardiology, electrophysiology, prevention, Asian epidemiology, health screening
+
+## Article Types Accepted
+- Original Investigation (Original Research)
+- State-of-the-Art Review
+- Mini-Focus / Special Series
+- Research Letter
+- Editorial / Viewpoint (invited)
+- Letter to the Editor
+
+## Classification
+- **Tier:** Emerging Q1 (JACC family; SCI indexing expected 2027, anticipated IF ~5–6)
+- **Open Access:** Full Gold OA
+- **Field:** Cardiovascular medicine — Asia-Pacific focus
+
+## Special Notes
+JACC: Asia is the youngest member of the JACC family (launched 2021) and is positioned as the regional flagship for Asian cardiovascular evidence; Asian-data specificity, regional generalizability, and policy relevance to Asia-Pacific healthcare systems are explicitly weighed in editorial assessment. Original Investigations are capped at 5,000 words including text, references, and figure legends combined, with a 250-word structured abstract (Background/Objectives/Methods/Results/Conclusions). References use Vancouver superscript, list first 3 authors plus et al., and use Index Medicus abbreviations. AI policy: follows Elsevier/ICMJE — language editing only, must be disclosed in both the cover letter and the Acknowledgments, AI cannot be listed as author, and AI-generated images are not permitted unless explicitly declared.

package/skills/find-journal/references/journal_profiles/JACR.md

@@ -0,0 +1,28 @@
+# Journal of the American College of Radiology
+
+## Identity
+- **Abbreviation:** J Am Coll Radiol
+- **Publisher:** Elsevier (American College of Radiology)
+- **ISSN:** 1546-1440 / 1558-349X
+- **Homepage:** https://www.jacr.org/
+- **Author guidelines:** https://www.jacr.org/content/authorinfo
+
+## Scope
+JACR publishes original research, opinions, and policy papers in five domains: health services research/policy, clinical practice management, data science, training/education, and leadership, focusing on how radiology is practiced, managed, and improved at the systems level.
+
+## Scope Keywords
+health services research, radiology policy, imaging utilization, practice management, radiology workforce, value-based imaging, appropriateness criteria, clinical decision support, radiology education, quality metrics, patient safety, AI implementation, healthcare economics, radiology leadership, data science
+
+## Article Types Accepted
+- Original Article
+- Brief Report (invited only)
+- Opinion
+- Letter to the Editor
+
+## Classification
+- **Tier:** Q1
+- **Open Access:** Hybrid
+- **Field:** Radiology / Health policy / Practice management
+
+## Special Notes
+JACR is the official journal of the American College of Radiology, uniquely positioned at the intersection of radiology and health policy. Does not publish clinical reviews, book reviews, or case reports. Strict author limits (Original Article <= 7 authors). Requires a Summary Sentence (<35 words) and Take Home Points (3-6 bullets) instead of a traditional Conclusions section. AI policy: language editing only, must disclose use, AI cannot be listed as author.

package/skills/find-journal/references/journal_profiles/JAMA.md

@@ -0,0 +1,40 @@
+# JAMA
+
+## Identity
+- **Abbreviation:** JAMA
+- **Publisher:** American Medical Association
+- **ISSN:** 0098-7484 / 1538-3598
+- **Homepage:** https://jamanetwork.com/journals/jama
+- **Author guidelines:** https://jamanetwork.com/journals/jama/pages/instructions-for-authors
+
+## Scope
+JAMA publishes original research, reviews, and opinion across all fields of medicine. It emphasizes studies with broad clinical relevance, public health implications, and policy impact. The journal values rigorous methodology, large-scale studies, and findings that inform clinical decision-making or health care delivery.
+
+## Scope Keywords
+clinical research, public health, health policy, randomized controlled trial, epidemiology, clinical outcomes, therapeutics, preventive medicine, health equity, evidence-based medicine, screening, diagnosis, treatment, global health, medical education
+
+## Article Types Accepted
+- Original Investigation
+- Research Letter
+- Review
+- Clinical Review and Education
+- Viewpoint
+- Editorial
+- Preliminary Communication
+- Special Communication
+- JAMA Diagnostic Test Interpretation
+
+## Classification
+- **Tier:** Q1
+- **Open Access:** Hybrid (optional OA)
+- **Field:** General medicine
+
+## Special Notes
+JAMA and JAMA Network journals (JAMA Internal Medicine, JAMA Surgery, JAMA Network Open, etc.) share a submission system. If rejected from JAMA, authors can transfer to a JAMA Network specialty journal. JAMA has a strong statistical review process and values structured reporting. Diagnostic accuracy studies and AI papers are considered if they demonstrate clear clinical utility.
+
+## AI Writing Disclosure Policy
+- **Requirement level:** Required
+- **Permitted scope:** Language editing only
+- **Disclosure location:** Methods + Cover letter
+- **AI-generated images:** Not specified — disclosure required if used
+- **Policy URL:** https://jamanetwork.com/journals/jama/pages/instructions-for-authors#702720037